United States Cancer Statistics: 2002 INCIDENCE AND MORTALITY docx

United

States

Cancer

Statistics

2002 INCIDENCE AND MORTALITY

PUBLICATION YEAR 2005

U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Program of Cancer Registries (NPCR)

National Center for Chronic Disease

Prevention and Health Promotion

Centers for Disease Control and Prevention

4770 Buford Highway, MS K-53

Atlanta, GA 30341-3717

Phone: (770) 488-4783

Fax: (770) 488-4759

http://www.cdc.gov/cancer/npcr

National Center for Health Statistics

Centers for Disease Control and Prevention

3311 Toledo Road

Hyattsville, MD 20782-2064

Phone: (301) 458-4000

E-mail: [email protected]

http://www.cdc.gov/nchs

Surveillance, Epidemiology, and End

Results (SEER) Program

Surveillance Research Program

Division of Cancer Control and Population

Sciences

National Cancer Institute

Suite 504, MSC 8316

6116 Executive Boulevard

Bethesda, MD 20892-8316

Phone: (301) 496-8510

Fax: (301) 496-9949

http://seer.cancer.gov

For more information, contact

Suggested citation: U.S. Cancer Statistics Working Group. United States Cancer Statistics:

2002 Incidence and Mortality. Atlanta: U.S. Department of Health and Human Services,

Centers for Disease Control and Prevention and National Cancer Institute; 2005.

All material in this report is in the public domain and may be reproduced or copied

without permission. However, citation as to source is requested.

United States Cancer Statistics will be published annually. All sections of this report are available

on the Web sites listed below:

• http://www.cdc.gov/cancer/npcr/uscs

• http://seer.cancer.gov/statistics

A CD-ROM of this report may be ordered at http://www.cdc.gov/cancer/npcr/uscs.

Web-site addresses of nonfederal organizations are provided solely as a service to our

readers. Their provision does not constitute an endorsement of these organizations

by CDC or the federal government, and none should be inferred. CDC is not

responsible for the content of other organizations’ Web pages. The Web-site

addresses listed in this report were accurate as of November 2005.

United

States

Cancer

Statistics

2002 Incidence and Mortality

U.S. Cancer Statistics Working Group

ii

U.S. Cancer Statistics Working Group

Editors

Centers for Disease North American Association

Control and Prevention National Cancer Institute of Central Cancer Registries

National Center for Chronic Brenda K. Edwards, PhD Holly L. Howe, PhD

Disease Prevention and Marsha E. Reichman, PhD Betsy A. Kohler, MPH, CTR

Health Promotion

Lyn Almon, MSPH

Cheryll Cardinez, MSPH

Temeika Fairley, PhD

Robert R. German, DrPH

Donald Haverkamp, MPH

Patricia M. Jamison, MPH

Jessica B. King, MPH

Joseph D. Rogers, BS

Sherri L. Stewart, PhD

Trevor D. Thompson, BS

Hannah K. Weir, PhD

Phyllis A. Wingo, PhD, MS

National Center for Health Statistics

Robert N. Anderson, PhD

United States Cancer Statistics: 2002 Incidence and Mortality

iii

The Centers for Disease Control and Prevention and the National Cancer

Institute thank the staff in state and metropolitan area cancer registries for their

commitment to cancer surveillance and control programs. The consistent efforts

of registry staff to collect complete, timely, and high-quality cancer incidence

data are essential for monitoring progress toward reducing the burden of cancer

in the United States. Appendix A provides a list of state and metropolitan area

cancer registries in the National Program of Cancer Registries (NPCR) and the

Surveillance, Epidemiology, and End Results (SEER) program.

We thank the NPCR’s Scientific Working Group members (Appendix B) for

their assistance in designing and reviewing this report.

We also wish to thank vital registration and statistics staff in the 50 states, New

York City, and the District of Columbia for their efforts to provide high-quality,

timely, and comparable mortality data.

National partner organizations are crucial to the success of cancer registration

and cancer surveillance in the United States. This report, and many advances in

cancer surveillance in the United States, would not have been possible without

the tireless efforts and many achievements of these organizations. The Centers

for Disease Control and Prevention and the National Cancer Institute gratefully

acknowledge and thank the American Cancer Society, the American College of

Surgeons Commission on Cancer, the American Joint Committee on Cancer,

the National Cancer Registrars Association, and our collaborating partner, the

North American Association of Central Cancer Registries, for their support for

cancer registration and cancer surveillance provided over many years. Appendix

C has contact information for these national partner organizations.

We wish to thank several people from the Centers for Disease Control and

Prevention: Kimbelian Barnes, Ryan Intlekofer, Karen Ledford, Mary Lewis,

Fran Michaud, Phyllis (Janie) Nichols, and Reda Wilson for verifying the data

and assisting with the appendices; Gayle Clutter and Dr. Roger E. McLendon

for their assistance in preparing and reviewing the data on brain cancer by

histologic group; and Dr. Harland Austin for his expert contributions to the

Technical Notes and Appendix L.

Additionally, we would like to acknowledge several people who were involved in

the production and distribution of this year’s report: Kathleen Carey, Mary

Kaeser, Diana Toomer, and the Division of Cancer Prevention and Control Web

Development Team: Phuong Huynh, Aimee Murphy, Shannon Orr, Marcy

Pendley, Blakeslee Potter, Wies Rafi, Corey Schuman, and Ramesh Thalluru.

Publication support was provided by Palladian Partners, Inc., under Contract

No. 200-980-0415 for the National Center for Chronic Disease Prevention

and Health Promotion, Centers for Disease Control and Prevention, U.S.

Department of Health and Human Services.

Acknowledgments

v

Preface

United States Cancer Statistics: 2002 Incidence and Mortality is a joint

publication of the Centers for Disease Control and Prevention (CDC)

in Atlanta, Georgia; the National Cancer Institute (NCI) in Bethesda,

Maryland; and the North American Association of Central Cancer

Registries (NAACCR) in Springfield, Illinois. This is the fourth annual

joint report produced, in collaboration with NAACCR, by the two

federal programs that support population-based cancer registries in the

United States: CDC’s National Program of Cancer Registries (NPCR)

and NCI’s Surveillance, Epidemiology, and End Results (SEER)

Program. This report contains official federal government cancer

statistics for more than 1 million invasive cancer cases diagnosed during

2002 among residents of 44 states, 6 metropolitan areas, and the

District of Columbia, and these geographic areas are inhabited by about

93% of the U.S. population. Data from population-based central cancer

registries in these states and metropolitan areas meet the selected

criteria for inclusion in this report (see “Registry Eligibility Criteria” in

the Technical Notes).

In addition to cancer incidence data, we present cancer mortality data

collected and processed by CDC’s National Center for Health Statistics

(NCHS). Mortality statistics, based on records of deaths that occurred

during 2002, are available for all 50 states and the District of Columbia.

The age-adjusted incidence and death rates are adjusted to the 2000

U.S. standard population, consistent with rates published in previous

United States Cancer Statistics reports. Readers should not compare these

data with published cancer rates that were not adjusted to the 2000 U.S.

standard.

The race and ethnicity categories have been expanded this year to

include national cancer incidence and mortality data for American

Indians/Alaska Natives. In addition, malignant brain and central

nervous system cancer incidence data are provided for the United

States, categorized by histologic subtype, age, and sex. In future

reports, more comprehensive cancer statistics will be provided while

maintaining high-quality data standards.

A Web-based version of the report with current (2002) and updated

(1999–2001) cancer incidence and mortality statistics is available at

http://www.cdc.gov/cancer/npcr/uscs. Data at this Web site are

provided in an HTML format that can be viewed in a variety of ways.

A downloadable ASCII-formatted version of the data that can be

manipulated to meet the needs of the user is also available.

vii

Acknowledgments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . iii

Preface . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . v

List of Tables, Figures, and Appendices . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ix

Executive Summary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . xv

Format for Numbering the Tables and Figures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . xxi

Technical Notes

Background . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

Federal Programs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

Collaborating Partner . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3

Data Sources . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4

Registry Eligibility Criteria . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7

Populations Covered by This Report . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8

Statistical Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8

Interpreting the Data . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11

HTML Edition of United States Cancer Statistics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17

References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17

Cancer Incidence and Mortality for Adults and Children: All Areas Combined . . . . . . . . . . . . . . . . 25

Cancer Incidence and Mortality by U.S. Census Region and Division, State,

and Metropolitan Area . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 51

State and Metropolitan Area Incidence Rates and State Death Rates for the

Most Common Cancers . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 236

Appendices

List of Abbreviations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Inside back cover

Table of Contents

ix

List of Tables, Figures, and Appendices

Cancer Incidence and Mortality for Adults and Children: All Areas Combined

Figure 1 Geographic Areas Contributing Data to United States Cancer

Statistics: 2002 Incidence and Mortality . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 25

Tables 1.1.1.1M– Age-adjusted invasive cancer incidence and death rates and

1.1.1.2F 95% confidence intervals by primary site, race and ethnicity,

and sex, United States, 2002 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 26

Tables 1.1.2.1M– All cancer sites combined. Invasive cancer incidence and death

1.1.2.2F rates and 95% confidence intervals by age, race and ethnicity,

and sex, United States, 2002 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 34

Tables 1.2.1.1M– Age-adjusted invasive cancer incidence rates and 95% confidence

1.2.1.1F intervals for ages 0–19 by International Classification of Childhood

Cancer (ICCC) group and subgroup, race and ethnicity, and sex,

United States, 2002 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 38

Table 1.2.2.1 Age-Adjusted Invasive Cancer Incidence Rates and 95% Confidence

Intervals by International Classification of Childhood Cancer

(ICCC) Group and Subgroup and Age, United States. All Races,

Males and Females, 2002 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 42

Table 1.2.3.1 Invasive Cancer Incidence Rates and 95% Confidence Intervals by

International Classification of Childhood Cancer (ICCC) Group and

Subgroup and Age, United States. All Races, Males and Females, 2002 . . . . . . 44

Tables 1.2.4.1M– Childhood age-adjusted invasive cancer incidence and death rates

1.2.4.2F and 95% confidence intervals for ages 0–19 by primary site, race

and ethnicity, and sex, United States, 2002 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 46

Tables 1.2.5.1– Childhood age-adjusted invasive cancer incidence and death rates

1.2.5.2 and 95% confidence intervals by primary site and age, United States.

All races, males and females, 2002 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 48

Tables 1.2.6.1– Childhood invasive cancer incidence and death rates and 95%

1.2.6.2 confidence intervals by primary site and age, United States.

All races, males and females, 2002 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 49

Table 1.3.1.1 Age-Adjusted Invasive Cancer of the Brain and Other Nervous System

Incidence Rates and 95% Confidence Intervals by Standard Histology

Group and Subgroup, Age, and Sex, United States. All Races, 2002 . . . . . . . . . 50

Cancer Incidence and Mortality by U.S. Census Region and Division, State, and

Metropolitan Area

Figure 2 Geographic Areas Contributing Data to United States Cancer Statistics:

2002 Incidence and Mortality, by U.S. Census Region and Division . . . . . . . . . . . 51

United States Cancer Statistics: 2002 Incidence and Mortality

x

Tables 2.1.1.1M– Age-adjusted cancer incidence and death rates and 95% confidence

2.27.1.2F intervals by U.S. Census region and division, state, metropolitan area,

and race and ethnicity, by primary site and sex, United States, 2002

All Cancer Sites Combined . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 52

Brain and Other Nervous System . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 60

Breast . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 68

Breast, in situ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 72

Cervix Uteri . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 74

Colon and Rectum . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 78

Corpus and Uterus, NOS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 86

Esophagus . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 90

Hodgkin Lymphoma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 98

Kaposi Sarcoma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 106

Kidney and Renal Pelvis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 110

Larynx . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 118

Leukemias . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .126

Liver and Intrahepatic Bile Duct . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 134

Lung and Bronchus . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 142

Melanomas of the Skin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 150

Mesothelioma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 158

Multiple Myeloma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 166

Non-Hodgkin Lymphoma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 174

Oral Cavity and Pharynx . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 182

Ovary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 190

Pancreas . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 194

Prostate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 202

Stomach . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 206

Testis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 214

Thyroid . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 218

Urinary Bladder . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 226

xi

State and Metropolitan Area Incidence Rates and State Death Rates for the

Most Common Cancers

Figures 3.1.M1– Age-adjusted cancer incidence and death rates for the 10 primary

3.58.F2 sites with the highest rates within race- and ethnic-specific categories,

by geographic area and sex, 2002

United States . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 236

Alabama . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 240

Alaska . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 244

Arizona . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 248

Arkansas . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 252

California . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 256

Los Angeles . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 260

San Francisco-Oakland . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 264

San Jose-Monterey . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 268

Colorado . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 272

Connecticut . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 276

Delaware . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 280

District of Columbia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 284

Florida . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 288

Georgia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 292

Atlanta . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 296

Hawaii . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 300

Idaho . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 304

Illinois . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 308

Indiana . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 312

Iowa . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 316

Kansas . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 320

Kentucky . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 324

Louisiana . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 328

Maine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 332

Maryland . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 336

Massachusetts . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 340

List of Tables, Figures, and Appendices

United States Cancer Statistics: 2002 Incidence and Mortality

xii

Michigan . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 344

Detroit . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 348

Minnesota . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 352

Mississippi . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 356

Missouri . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 360

Montana . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 364

Nebraska . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 368

Nevada . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 372

New Hampshire . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 376

New Jersey . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 380

New Mexico . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 384

New York . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 388

North Carolina . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 392

North Dakota . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 396

Ohio . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 400

Oklahoma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 404

Oregon . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 408

Pennsylvania . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 412

Rhode Island . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 416

South Carolina . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 420

South Dakota . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 424

Tennessee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 428

Texas . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 432

Utah . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 436

Vermont . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 440

Virginia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 444

Washington . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 448

Seattle-Puget Sound . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 452

West Virginia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 456

Wisconsin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 460

Wyoming . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 464

xiii

Appendices

Appendix A State and Metropolitan Area Cancer Registries

Appendix B National Program of Cancer Registries: Scientific Working Group Members

Appendix C National Partner Organizations

Appendix D Invasive cancer incidence counts and cancer death counts by primary

site, sex, race and ethnicity, and age (all ages, <1, 1–4, 5–9, 10–14, 15–19,

and 0–19), United States, 2002

Appendix E Invasive cancer incidence counts and cancer death counts by U.S. Census

region and division, state, metropolitan area, sex, and race and ethnicity,

United States, 2002

Appendix F Age-adjusted invasive cancer incidence and death rates and

95% confidence intervals for Asians/Pacific Islanders and American

Indians/Alaska Natives by state, metropolitan area, primary site, and sex,

United States, 2002

Appendix G State and Metropolitan Area Cancer Registries by Affiliation in

Federal Cancer Surveillance Program, 2005

Appendix H State, Metropolitan Area, and Territory Cancer Registries by Federal

Funding Source and First Diagnosis Year for Which Cancer Cases Were

Reportable to CDC’s NPCR or NCI’s SEER Program

Appendix I Data quality criteria for cancer incidence and mortality data

Appendix J Primary cancer site, histology, and cause-of-death codes based on International

Classification of Diseases: ICD–O–3 (incidence) and ICD–10 (mortality)

Appendix K Population counts by U.S. Census region and division, state, metropolitan

area, sex, age (all ages, ages 0–19), and race and ethnicity, 2002

Appendix L Criteria for Reporting Age-Adjusted Cancer Incidence Rates for U.S.

Census Regions and Divisions

List of Tables, Figures, and Appendices